Trial Profile
Entecavir Intensification for Persistent Hepatitis B Virus (HBV) Viremia in HIV-HBV Infection
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Entecavir (Primary) ; Emtricitabine; Lamivudine; Tenofovir disoproxil fumarate
- Indications Hepatitis B
- Focus Therapeutic Use
- 22 Feb 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 29 Mar 2010 Results were presented at the 17th Conference on Retroviruses and Opportunistic Infections.
- 19 May 2008 New trial record.